Literature DB >> 23399577

Transplantation: Immunosuppression and risk of polyomavirus BK replication.

Phuong-Thu T Pham1, Uttam G Reddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23399577     DOI： 10.1038/nrneph.2013.17

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia.

Authors:  Daniel L Bohl; Gregory A Storch; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Mark A Schnitzler; Eugene O Major; Daniel C Brennan
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

2.  Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss.

Authors:  I Binet; V Nickeleit; H H Hirsch; O Prince; P Dalquen; F Gudat; M J Mihatsch; G Thiel
Journal:  Transplantation       Date:  1999-03-27       Impact factor: 4.939

3.  Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

Authors:  F Vincenti; S Friman; E Scheuermann; L Rostaing; T Jenssen; J M Campistol; K Uchida; M D Pescovitz; P Marchetti; M Tuncer; F Citterio; A Wiecek; S Chadban; M El-Shahawy; K Budde; N Goto
Journal:  Am J Transplant       Date:  2007-03-12       Impact factor: 8.086

4.  In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells.

Authors:  P D Acott; P A O'Regan; S H Lee; J F S Crocker
Journal:  Transpl Infect Dis       Date:  2008-07-28       Impact factor: 2.228

5.  Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Authors:  Dany Anglicheau; Martin Flamant; Marie Hélène Schlageter; Frank Martinez; Bruno Cassinat; Philippe Beaune; Christophe Legendre; Eric Thervet
Journal:  Nephrol Dial Transplant       Date:  2003-11       Impact factor: 5.992

6.  BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results.

Authors:  K L Hardinger; M J Koch; D J Bohl; G A Storch; D C Brennan
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

7.  Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States.

Authors:  Jesse D Schold; Shezhad Rehman; Liise K Kayle; Liise K Kayler; Joseph Magliocca; Titte R Srinivas; Herwig-Ulf Meier-Kriesche
Journal:  Transpl Int       Date:  2009-02-02       Impact factor: 3.782

8.  Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study.

Authors:  Wana Manitpisitkul; Cinthia Drachenberg; Emilio Ramos; Raghava Munivenkatappa; Benjamin Philosophe; David Klassen; Abdolreza Haririan
Journal:  Transplantation       Date:  2009-07-15       Impact factor: 4.939

9.  Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.

Authors:  H H Hirsch; F Vincenti; S Friman; M Tuncer; F Citterio; A Wiecek; E H Scheuermann; M Klinger; G Russ; M D Pescovitz; H Prestele
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086
  9 in total
  2 in total

1.  [Characteristics of BK polymavirus infection in kidney transplant recipients].

Authors:  Yi Zhou; Leiyu Yao; Zhe Yu; Naiqian Cui; Fangxiang Fu; Yuedian Ye; Wenfeng Deng; Jian Xu; Shaojie Fu; Ruming Liu; Lixin Yu; Yun Miao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

2.  A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients.

Authors:  Lilli Gard; Willem van Doesum; Hubert G M Niesters; Willem J van Son; Arjan Diepstra; Coen A Stegeman; Henk Groen; Annelies Riezebos-Brilman; Jan Stephan Sanders
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.